OTC
FDA Warns of Infection Risk From OTC Eye Drops
The FDA recommended that manufacturers recall more than 20 eye drop products sold over the counter in retail ...
OCTOBER 31, 2023
California Governor Vetoes Bill Requiring Insurance to Cover Low-Cost Naloxone
A bill that would require California insurers to cover the cost of OTC naloxone was vetoed by the state’s ...
OCTOBER 31, 2023
Anti-Infective Rx Interactions, Sports Med Doping and More
LAS VEGAS—Tips on potential interactions to watch between antibiotics and over-the-counter (OTC) medications, ...
APRIL 20, 2023
FDA Approves OTC Version of Opioid Overdose Reversal Agent
The FDA approved the OTC version of naloxone nasal spray to rapidly reverse the effects of opioid overdose.
MARCH 29, 2023
Older Adults Often Use Varied Treatment Options for Joint Pain, but No Real Strategy
Nearly half of people over 50 years of age say arthritis or joint pain limits their usual activities, but many ...
NOVEMBER 14, 2022
Sanofi and Roche Reach Tamiflu Deal
Sanofi will be responsible for leading FDA negotiations for the OTC switch and subsequent exclusive marketing, ...
JULY 24, 2019
